Eleva Capital’s Aquestive Therapeutics AQST Stock Holding History

Eleva Capital’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2,720	Closed	-$11.3K	–	28
2026 Q2	$11.3K	Hold	2,720	–	–	﹤0.01%	24
2026 Q1	$11.3K	Buy	+2,720	New	+$11K	﹤0.01%	24

Other funds holding AQST

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Eleva Capital's AQST Position: Q3 2026 in Review

Eleva Capital sold out of Aquestive Therapeutics (AQST) in Q3 2026, closing a stake of 2,720 shares — an estimated $11.3K sold.

Eleva Capital first reported a position in AQST in Q1 2026 and held it in 2 quarters. The position peaked at $11.3K in Q2 2026. 1 fund tracked by Wall St. Rank holds AQST as of Q3 2026.

Eleva Capital reported no remaining Aquestive Therapeutics position as of Q3 2026 after selling out during the quarter.
Eleva Capital sold 2,720 Aquestive Therapeutics shares in Q3 2026, an estimated $11.3K.
Eleva Capital first reported a position in Aquestive Therapeutics in Q1 2026 and held it in 2 quarters.
Eleva Capital's Aquestive Therapeutics position peaked at $11.3K in Q2 2026.
1 fund tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on Eleva Capital's 13F filing for Q3 2026, filed 6 Oct 2026.